XML 43 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated (Deficit) Earnings and Cumulative Distributions
Accumulated (Deficit) Earnings and Cumulative Distributions
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interests
Non-controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total Equity
Total Equity
Cumulative Effect, Period of Adoption, Adjustment
Class S Common Shares
Common Stock
Class N Common Shares
Common Stock
Class D Common Shares
Common Stock
Class I Common Shares
Common Stock
Beginning balance at Dec. 31, 2022   $ 736,083 $ (5,162)   $ 744,852 $ 3,678 $ (13,212) $ (5,162) $ 293,567 $ (1,995) $ 1,029,650 $ (7,157) $ 434 $ 0 $ 14 $ 317
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued   1,247,005     1,245,790           1,247,005   482   32 701
Offering costs   (37,083)     (37,083)           (37,083)          
Distribution reinvestment   40,679     40,639           40,679   20   1 19
Common share repurchases   (38,425)   $ (38,425) (38,387)           (38,425)   (15)   (2) (21)
Amortization of restricted stock grants   170     170           170          
Net income (loss)   (19,907)         (19,907)   (888)   (20,795)          
Other comprehensive income (loss) $ 142 (626)       (626)     890   264          
Distributions declared on common shares   (94,357)         (94,357)       (94,357)          
Redeemable common share measurement adjustment   4     4           4          
Contributions from non-controlling interests                 126   126          
Distributions to and redemptions of non-controlling interests                 (41,832)   (41,832)          
Redeemable non-controlling interests measurement adjustment   (586)     (586)           (586)          
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership   (7,044)     (7,044)       6,847   (197)          
Ending balance at Dec. 31, 2023   1,820,751     1,948,355 3,052 (132,638)   256,715   2,077,466   921 0 45 1,016
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued   2,354,791     2,352,467           2,354,791   966 151 19 1,188
Offering costs   (65,041)     (65,041)           (65,041)          
Distribution reinvestment   102,415     102,314           102,415   48 1 1 51
Common share repurchases   (176,039)   (176,039) (175,865)           (176,039)   (64)     (110)
Converted common shares         1           0   (1)   (47) 47
Amortization of restricted stock grants   395     395           395          
Net income (loss)   160,292         160,292   11,492   171,784          
Other comprehensive income (loss) (22,200) (21,170)       (21,170)     (847)   (22,017)          
Distributions declared on common shares   (214,951)         (214,951)       (214,951)          
Redeemable common share measurement adjustment   (227)     (227)           (227)          
Contributions from non-controlling interests                 174   174          
Distributions to and redemptions of non-controlling interests                 (29,457)   (29,457)          
Redeemable non-controlling interests measurement adjustment   (862)     (862)           (862)          
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership   (12,175)     (12,175)       11,242   (933)          
Ending balance at Dec. 31, 2024 4,197,498 3,948,179     4,149,362 (18,118) (187,297)   249,319   4,197,498   1,870 152 18 2,192
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued   3,208,527     3,205,401           3,208,527   1,232 322 60 1,512
Offering costs   (98,733)     (98,733)           (98,733)          
Distribution reinvestment   194,234     194,048           194,234   87 9 2 88
Common share repurchases   (331,163)   $ (331,163) (330,841)           (331,163)   (94) (5) (3) (220)
Converted common shares                     0   (25)   12 13
Amortization of restricted stock grants   212     212           212          
Net income (loss)   465,032         465,032   20,496   485,528          
Other comprehensive income (loss) 18,295 17,363       17,363     622   17,985          
Distributions declared on common shares   (385,791)         (385,791)       (385,791)          
Redeemable common share measurement adjustment   (268)     (268)           (268)          
Contributions from non-controlling interests   4,915     4,915       17,963   22,878          
Distributions to and redemptions of non-controlling interests                 (52,585)   (52,585)          
Redeemable non-controlling interests measurement adjustment   (2,488)     (2,488)           (2,488)          
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership   (3,199)     (3,199)       2,764   (435)          
Ending balance at Dec. 31, 2025 $ 7,255,399 $ 7,016,820     $ 7,118,409 $ (755) $ (108,056)   $ 238,579   $ 7,255,399   $ 3,070 $ 478 $ 89 $ 3,585